Ocular Gene Therapy


Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.


  • Gene replacement
  • DNA Nanoparticle
  • RNA Interference
  • Ex vivo for Retinal Pigmentosa

Related Conference of Ocular Gene Therapy

September 16-17, 2025

20th International Conference on Ophthalmology and Vision Science

Amsterdam, Netherlands
September 22-23, 2025

8th International Eye and Vision Congress

Amsterdam, Netherlands
October 20-21, 2025

6th World Congress on Ophthalmology and Vision Science

Barcelona, Spain
November 03-04, 2025

39th European Ophthalmology Congress

Rome, Italy
January 12-13, 2026

26th Global Ophthalmologists Annual Meeting

London, UK
April 20-21, 2026

3rd International Conference on Ophthalmology

Barcelona, Spain

Ocular Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in